Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06286930 · ClinicalTrials.gov registry record · NA

Cerebellar tDCS Stimulation in Children and Adult Women With Anorexia Nervosa Disorder

A NA study of Anorexia Nervosa, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06286930: Recruiting NA study of Anorexia Nervosa, sponsored by University of Texas Southwestern Medical Center.

NCT06286930 is a NA study of Anorexia Nervosa that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 15 participants, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06286930, a NA study of Anorexia Nervosa, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Hypothesis: Will the use of tDCS brain modulation in the cerebellum assist in restricted behaviors, social cognition and cognitive flexibility in women with anorexia nervosa in addition to other therapies? Primary Outcomes: 1. To observe the impacts and outcomes of cerebellar transcranial direct current stimulation (tDCS) on social behaviors measured by Cyberball and Trust Game. 2. To observe the neuropsychological impacts of cerebellar tDCS through fMRI imaging as well as looking at the Region of Interest (ROI) of changes in the Default Mode Network and Cerebellum circuits and their activation levels in those networks. Secondary Outcomes: 1.To observe the impacts and outcome of cerebellar transcranial direct current stimulation (tDCS) measuring the differences between anodal and cathodal stimulation. To observe potential increases in responses to social stimuli, decreases in eating disorder/depressive symptomology via cathodal stimulation. To also observe potential little to no changes in social stimuli and eating disorder/depressive symptomology via anodal stimulation.

Primary Outcome

To observe the impacts and outcomes of cerebellar transcranial direct current stimulation (tDCS) on social behaviors measured by Cyberball. Cyberball is a virtual ball toss game utilized to measure ostracism, social exclusion, rejection, etc. This measure predicts whether or not the behavior of the participant will change how they react to the game after receiving transcranial direct current stimulation (tDCS).

Conditions Studied

Interventions

  • DEVICE anodal trans cranial direct current stimulation (tDCS)
  • DEVICE cathodal trans cranial direct current stimulation (tDCS)

Study Locations (1)

Texas

  • UT Southwestern Multispecialty Psychiatry Clinic - Dallas

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-04-24
Est. Completion 2027-01-02
Phase NA

What NCT06286930 shows while recruiting

NCT06286930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which anodal trans cranial direct current stimulation (tDCS) is the first listed.

NCT06286930 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06286930 about?

NCT06286930 is a clinical study titled "Cerebellar tDCS Stimulation in Children and Adult Women With Anorexia Nervosa Disorder". Hypothesis: Will the use of tDCS brain modulation in the cerebellum assist in restricted behaviors, social cognition and cognitive flexibility in women with anorexia nervosa in addition to other therapies? Primary Outcomes: 1. To observe the impacts and outcomes of cerebellar transcranial direct c...

What is the current status of trial NCT06286930?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-04-24. Estimated completion is 2027-01-02.

What conditions does trial NCT06286930 study?

This clinical trial studies the following conditions: Anorexia Nervosa.

What interventions are being tested in trial NCT06286930?

The interventions under investigation include: anodal trans cranial direct current stimulation (tDCS) (DEVICE), cathodal trans cranial direct current stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT06286930?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06286930 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06286930's enrollment target sits among peer trials

15 43rd of 43 higher than 1 of 43 other Anorexia Nervosa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06286930, the US trial registry maintained by the National Library of Medicine. NCT06286930 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.